Volume 28, Issue 8 (Monthly_Nov 2017)
Studies in Medical Sciences 2017, 28(8): 1-7 |
Back to browse issues page
University of Medical Science of urimia , fatemehkarimi120@yahoo.com
Abstract: (22400 Views)
Background & Aims: Breast cancer is the second most common cancer in women, with the peak frequency of a decade lower than the global age. The aim of this cross sectional study is to estimate the burden of breast cancer in women in Western Azerbaijan Province in 2013.
Materials & Methods: In this cross-sectional study, the information needed to calculate YLD and YLL creating the total DALY including the female population, the mortality, incidence and mean time stage of breast cancer that were obtained from death registration system of cancer registry. The standard World Health Organization (discount rate 0.03 0.04 Weight age, and fixed adjusted 0.165) was used to calculate YLL and YLD and all the information collected and entered into EXCEL TEMPLATE software and the calculations were carried out.
Results: The entire burden of lost years of life due to breast cancer in 2013 was 1645 years. YLL in 2013, was equaled to1385 years while the share of YLD was calculated as 260 years. DALY rate per hundred thousand female populations was 1.1 years. Breast cancer incidence and death rate per hundred thousand women in 2013 were 14.2 and 4.7, respectively, that the peak age of breast cancer has been accessed in the age group of 45-59.
Conclusion: The incidence, mortality and the burden of breast cancer in women have been raised compared to the study last year. The findings may help managers through the awareness of factors affecting the burden of disease, preventative measures and the idea of screening and early detection of breast cancer.
Materials & Methods: In this cross-sectional study, the information needed to calculate YLD and YLL creating the total DALY including the female population, the mortality, incidence and mean time stage of breast cancer that were obtained from death registration system of cancer registry. The standard World Health Organization (discount rate 0.03 0.04 Weight age, and fixed adjusted 0.165) was used to calculate YLL and YLD and all the information collected and entered into EXCEL TEMPLATE software and the calculations were carried out.
Results: The entire burden of lost years of life due to breast cancer in 2013 was 1645 years. YLL in 2013, was equaled to1385 years while the share of YLD was calculated as 260 years. DALY rate per hundred thousand female populations was 1.1 years. Breast cancer incidence and death rate per hundred thousand women in 2013 were 14.2 and 4.7, respectively, that the peak age of breast cancer has been accessed in the age group of 45-59.
Conclusion: The incidence, mortality and the burden of breast cancer in women have been raised compared to the study last year. The findings may help managers through the awareness of factors affecting the burden of disease, preventative measures and the idea of screening and early detection of breast cancer.
Type of Study: Research |
Subject:
Epidemiology
References
1. Vakili M, Jafarizade M, Sadeghian MZ, MirzaeiM,Norishadkam M, Lotfi MH, Harirchi I, et al. Estimation of breast cancer in Yazd province in 2006. Feyez 2009;13(1):41-6. [Article]
2. Naghavi M. Guidelines for calculating the burden of diseases for the national and provincial level. Tehran: Ministry of Health and Medical Education; 2006.
3. Naghavi M, Abolhassani F, Pourmalek F, Moradi Lakeh M, Jafari N, Vaseghi S, et al. The burden of disease and injury in Iran 2003. Population Health Metrics 2009;7:9. [PubMed]
4. World Health Organization. National burden of disease studies: practical guide. 2nd ed. Geneva: 2008. [Google Scholar]
5. Kolahdoozan S, Sadjadi A, Radmehr AR, Khademi, Hooman. Five Common Cancers in Iran. Teheran: Academy of Medical Sciences of I.R. Iran; 2010. [Google Scholar]
6. Cancer Registry Report in Iran. Center of management of noncontiguous diseases. Tehran: Ministry of Health and Medical Education; 2004.
7. Center for Disease Management, Health Deputy, Ministry of Health and Medical Education. National report on registration of cancer cases and 2009. Tehran: Kalk Deirin Publications; 2012. [Article]
8. Jafari N, Abolhassani F, Naghavi M, Pourmalek F, MoradiLakeh M, Kazemeini H, Kabir MJ, Health Network Development, National Burden of Disease and Study in Iran. Iran J Publ Health 2009; 38(1): 71-3. [Google Scholar]
9. Frahbakhash M. Study and Determine the Burden of Common Disease in East Azerbaijan province. Tabriz J Med Sci 2012; 34(1): 81-7. (Persian)
10. Rezagholi T, Yavari P, Abolhasani F, Etemad K, Khosravi A, HashemiNazari S, et al. Estimating the Burden of Breast Cancer in Iranian Women in 2009. Iran J Epidemiol 2015; 10(4): 32-40. [Article]
11. Abolhasani F, Khayamzadeh M, Moradi LM, Jamali A, Salmanian R, Naghavi M. Estimation of breast cancer burden in Iran in 2003 and its comparison with Eastern Mediterranean region and the World in 2002. Payesh 2007;6(3):233–41. [PubMed]
12. Coale A, Demeny P, Vaughan B. Regional model life tablesand stable populations. 2nd Ed. New York (NY): Academic Press; 1983. [Google Scholar]
13. Mathers C, Ma Fat D. The global burden of disease: 2004 update. Department of Health Statistics and Informatics in the Information, Evidence and Research Cluster of WHO. WHO Library Cataloguing-in-Publication Data 2004. [Google Scholar]
14. Pham T-M, Kubo T, Fujino Y, Ozasa K, Matsuda S, Yoshimura T. Disability-adjusted life years (DALY) for cancer in Japan in 2000. J Epidemiol 2011;21(4):309–12. [PubMed]
15. Yavari P, Mosavizadeh MA, Sadrolhefazi B, Khodabakhshi R, Madani H, Mehrabi Y. Reproductive Characteristics and the Risk of Breast Cancer: A CaseControl Study. Iran J Epidemiol 2006; 2: 11-9. [Google Scholar]
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |